From July 13 to 17, 2025, Kigali, Rwanda will host the 13th IAS Conference on HIV Science (IAS 2025), considered the world’s most influential meeting on HIV research. This biennial conference, organized by the International AIDS Society, showcases the latest innovations in HIV that bring cutting-edge science into policy and practice. IAS 2025 will also place special emphasis on long-acting injectable technologies and current political and financial issues affecting the HIV response, including their implications for Africa and the rest of the world.

The ImPrEP CAB Brazil project will once again be present at the conference, offering a diverse program featuring the results of scientific studies not only related to HIV pre-exposure prophylaxis (PrEP), but also addressing mpox and other sexually transmitted infections. A special highlight is the organization of the satellite symposium “Implementation of long-acting PrEP in real world settings – the ImPrEP project”, where the study protocol for ImPrEP LEN Brazil will be presented.

Check out the project’s program at the event:

Satellite Symposium “Implementation of long-acting PrEP in real world settings – the ImPrEP project” (room and channel MH2)

July 16th, Wednesday, available from 6:15 am (Brasília time) for conference registrants

Topics and participants:

– Welcome remarks and symposium overview, with Valdiléa Veloso (Evandro Chagas National Institute of Infectious Diseases, Oswaldo Cruz Foundation, Brazil – INI/Fiocruz)

– Opening remarks, with Philippe Duneton, Unitaid representative

– Implementation studies of long-acting PrEP as a pathway for public health policy, with Arthur Kalichman (Brazilian Ministry of Health)

– PrEP Choice and Coverage among young sexual and gender minorities – Results from the ImPrEP CAB Brasil Study, with Thiago Torres (INI/Fiocruz)

– PrEP choice and preferences: insights from the ImPrEP CAB Brasil Study, with Cristina Pimenta (INI/Fiocruz)

– Conditions for long-acting PrEP access and success, with Anne-Isabelle Cameron, Unitaid representative

– The ImPrEP LEN Brazil study protocol, with Beatriz Grinsztejn (INI/Fiocruz)

Posters

– Understanding preferences and transitioning between oral and injectable PrEP: insights from ImPrEP CAB Brasil Study, with Cristina Pimenta (INI/Fiocruz) et al (THPED075, Track D)

– Social Vulnerability and Psychosocial Factors Associated with Antiretroviral Adherence among Sexual and Gender Minorities Living with HIV in Brazil, Mexico, and Peru, with Hamid Vega-Ramirez (Ramón de la Fuente Muñiz National Institute of Psychiatry, Mexico) et al (EP0565, Track D)

– Mpox diagnosis and vaccination among gay and other men who have sex with men and transgender women in Brazil: results from a large nationwide on-line survey, with Thiago Torres (INI/Fiocruz) et al (EP1114, Track M)

-Current and Prior PrEP Use and Associated Factors among Sexual and Gender Minorities from Brazil, Mexico and Peru, with Kelika Konda (USC Keck School of Medicine – USA) et al (THPEC090, Track C)

– STI Diagnosis and interest in using doxy-PEP Among Men Who Have Sex with Men and Transgender Women in Brazil, with Mayara Secco (INI/Fiocruz) et al (EP0369, Track C)

– How Willing are Sexual and Gender Minorities to Use Pre-Exposure Prophylaxis Modalities? An Online Survey from Brazil, Mexico and Peru, with Jazmin Qquellon (Universidad Peruana Cayetano Heredia) et al (EP0360, Track C)

Also, check out the INI/Fiocruz program at the event:https://docs.google.com/spreadsheets/d/1vUKHm_n9VpILWnNydOEc4kM7Oj-Q-1T1sqBkI9uUl8w/edit?usp=sharing